Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04028570

A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy Using Extensive Pleural Resection

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to find the maximum tolerated dose level for malignant pleural mesothelioma patients receiving background radiation + boost radiation, and surgery. Boost radiation is an experimental form of radiation that involves targeting non-uniform high doses of radiation to bulky pleural masses. We hypothesize the immunologic abscopal effect is an important component in controlling disease, and may be stimulated with highly hypofractionated doses. Doses will increase with every three patients who will be enrolled in the study until the background radiation reaches 1800 cGy or the maximum tolerated dose, whichever is lower.

Detailed description

This study aims to find the maximum tolerated dose level for mesothelioma patients receiving background radiation + boost radiation, and surgery. 3 patients will start with a background radiation therapy (RT) dose of 0 cGy, and boost RT of at least 2100 cGy. If the radiation is manageable (radiation related AEs grade \< 4), the next set of 3 patients will be enrolled, and the background radiation dose will be increased by 600 cGy. This will continue until the background radiation dose reaches 1800 cGy. If 1 patient exhibits dose limiting toxicities (AEs grade 4 \& 5), the dose level will repeat with the next 3 patients. If 2 or more patients exhibit DLTs, the previous dose level will be determined as the maximum tolerated dose level. Surgery will be scheduled to occur approximately 1-2 weeks after completing radiation therapy, and will subsequently be followed up as per study schedule.

Conditions

Interventions

TypeNameDescription
RADIATIONVarying Doses of Background and Boost RT3+3 radiation dose escalation model to see the maximum tolerated dose for background and boost radiation therapy.

Timeline

Start date
2019-09-05
Primary completion
2027-04-01
Completion
2027-04-01
First posted
2019-07-22
Last updated
2026-03-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04028570. Inclusion in this directory is not an endorsement.

A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy Using Extensive Pleural Resection (NCT04028570) · Clinical Trials Directory